Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06421636
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-14
Brief Title:
A Study to Test the Safety Tolerability and Efficacy of an Antibody REGN7999 Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia Using MRI Scans to Measure Iron Levels in the Body
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals